J. Goldman & Co LP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 155 filers reported holding CARA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$321,000
-77.9%
18,800
-79.1%
0.02%
-80.8%
Q4 2019$1,450,000
+107.7%
89,983
+153.1%
0.10%
+166.7%
Q1 2019$698,000
-58.7%
35,554
-72.7%
0.04%
-70.0%
Q4 2018$1,690,000130,0000.13%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Chescapmanager LLC 1,304,903$20,161,0002.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 715,684$11,057,0001.34%
DISCIPLINED GROWTH INVESTORS INC /MN 1,669,089$25,787,0000.51%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 156,625$2,420,0000.37%
ALPINE WOODS CAPITAL INVESTORS, LLC 184,632$2,853,0000.30%
Campbell & CO Investment Adviser LLC 42,600$658,0000.21%
FARALLON CAPITAL MANAGEMENT LLC 2,000,000$30,900,0000.14%
PDT Partners, LLC 104,648$1,617,0000.12%
Virtus ETF Advisers LLC 14,798$229,0000.10%
PINNACLE ASSOCIATES LTD 338,922$5,236,0000.10%
View complete list of CARA THERAPEUTICS INC shareholders